Forge Therapeutics gets up to $11.1 million for drugs against ‘superbugs’

San Diego antibiotic developer Forge Therapeutics has received a grant of up to $11.1 million for a drug to fight antibiotic-resistant "superbugs."

Forge is getting initial funding of up to $5.7 million from a public-private partnership called CARB-X. It?s designated for research to find a drug…